US Patent 7786271 Antibodies that inhibit TSLP activity
Patent 7786271 was granted and assigned to Immunex on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+333 characters)
Article
Patent abstract
The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Allison P. Armstrong0
Hilary J. McKenna0
John E. Sims0
Stewart D. Lyman0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07786271 Antibodies that inhibit TSLP activity US Patent 7786271 Antibodies that inhibit TSLP activity
Infobox
Patent Number
07786271
Patent Number
7786271
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07786271 Antibodies that inhibit TSLP activity
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07786271
Date of patent
August 31, 2010
Patent application number
12220879
Date Filed
July 28, 2008
Patent primary examiner
Find more entities like US Patent 7786271 Antibodies that inhibit TSLP activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
